Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 916 AL 930

2-(6-[(11)C]Methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-9H-fluoren-9-one

Chopra A.

2013 Apr 9. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Anti-Parkinson's disease drugs and pharmacogenetic considerations

Agúndez JA, García-Martín E, Alonso-Navarro H, Jiménez-Jiménez FJ.

Expert Opin Drug Metab Toxicol. 2013 Jul;9(7):859-74. doi: 10.1517/17425255.2013.789018. Epub 2013 Apr 9.

Pharmacologic treatment of anxiety disorders in Parkinson disease

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L.

Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29.

[Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]

García-Gómez FJ, García-Solís D, Luis-Simón FJ, Marín-Oyaga VA, Carrillo F, Mir P, Vázquez-Albertino RJ.

Rev Esp Med Nucl Imagen Mol. 2013 Nov-Dec;32(6):350-6. doi: 10.1016/j.remn.2013.02.009. Epub 2013 Apr 6.

(1R,2R)-N-(3-(4-[(11)C]Methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropane-carboxamide

Leung K.

2013 Jan 18 [updated 2013 Apr 11]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

JNK inhibitors as anti-inflammatory and neuroprotective agents

Graczyk PP.

Future Med Chem. 2013 Apr;5(5):539-51. doi: 10.4155/fmc.13.34.

Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy

Witkin JM, Li X.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):487-97. doi: 10.2174/1871527311312040007.

Dilated Virchow-Robin spaces and parkinsonism

Mehta SH, Nichols FT 3rd, Espay AJ, Duker AP, Morgan JC, Sethi KD.

Mov Disord. 2013 May;28(5):589-90. doi: 10.1002/mds.25474. Epub 2013 Apr 10.

Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease

Borah A, Paul R, Mazumder MK, Bhattacharjee N.

Neurosci Bull. 2013 Oct;29(5):655-60. doi: 10.1007/s12264-013-1330-2. Epub 2013 Apr 10.

Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease

Storch A, Wolz M, Beuthien-Baumann B, Löhle M, Herting B, Schwanebeck U, Oehme L, van den Hoff J, Perick M, Grählert X, Kotzerke J, Reichmann H.

Neurology. 2013 May 7;80(19):1754-61. doi: 10.1212/WNL.0b013e3182918c2d. Epub 2013 Apr 10.

Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

Bartus RT, Baumann TL, Siffert J, Herzog CD, Alterman R, Boulis N, Turner DA, Stacy M, Lang AE, Lozano AM, Olanow CW.

Neurology. 2013 Apr 30;80(18):1698-701. doi: 10.1212/WNL.0b013e3182904faa. Epub 2013 Apr 10.

Unraveling the mysteries of motor cortical function in Parkinson disease

Mackinnon CD, Rothwell JC.

Neurology. 2013 May 7;80(19):1726-7. doi: 10.1212/WNL.0b013e3182918d4b. Epub 2013 Apr 10.

Chronic depression as a model disease for cerebral aging

Bewernick BH, Schlaepfer TE.

Dialogues Clin Neurosci. 2013 Mar;15(1):77-85. doi: 10.31887/DCNS.2013.15.1/bbewernick.

Diversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies

Sekigawa A, Takamatsu Y, Sekiyama K, Takenouchi T, Sugama S, Waragai M, Fujita M, Hashimoto M.

Oxid Med Cell Longev. 2013;2013:817807. doi: 10.1155/2013/817807. Epub 2013 Mar 14.

Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease

Boeve BF.

Lancet Neurol. 2013 May;12(5):469-82. doi: 10.1016/S1474-4422(13)70054-1. Epub 2013 Apr 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias